Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Steroid; AR antagonist.
Quinolone alkaloid precursor of irinotecan, ori...
nNOS inhibitor.
Chalcone kavalactone that suppresses inflammati...
Antitumor
Endogenous peptide hormone, increases extracell...
BK/SK, Kv1, Kv3, TASK-2 K+ channel blocker, vol...
Bisphosphonate; FPPS inhibitor.
Atazanavir metabolite; HIV protease inhibitor.<...
Tricyclic benzonaphthyridinone; mTORC1/2 inhibi...
HSP90 inhibitor.
GHB agonist, D2/3 antagonist.
Bisphosphonate.
Fatty acid synthase inhibitor.
Statin; HMG-CoA reductase inhibitor.
Histamine H1-antagonist
Macrolide; protein translation inhibitor, mamma...
Glucose metabolism inhibitor, N-linked glycosyl...
FAK inhibitor.
Toll-like receptor 7/8 agonist